Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 139-145

  Roe, M F E ^a   Bloxham, D M ^a   White, D K ^a   Ross Russell, R I ^a   Tasker, R T C ^a   O'Donnell, D R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Apoptosis; Bronchiolitis; Lymphocyte; Respiratory syncytial virus; Trail receptor virus

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DEATH RECEPTOR 5; FAS ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 1BETA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ACUTE DISEASE; APOPTOSIS; ARTICLE; BRONCHIOLITIS; CLINICAL ARTICLE; CYTOTOXIC LYMPHOCYTE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFANT; INFECTION; LYMPHOCYTE; LYMPHOCYTOPENIA; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; UPREGULATION;

AGE FACTORS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BRONCHIOLITIS; CASPASE 1; COHORT STUDIES; FEMALE; HUMANS; INFANT; INTERLEUKIN-18; LIGANDS; LYMPHOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; PROGNOSIS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 3042704734     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02512.x     Document Type: Article

References (39)

1. Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations 1997 to 1999. Pediatr Infect Dis J 2002; 21:629-32.
2. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 2003; 22:S76-82.
3. Hall CB, Powell KR, MacDonald NE, Gala CL, Menegus ME, Suffin SC, Cohen HJ. Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med 1986; 315:77-81.
4. Graham BS, Bunton LA, Wright PF, Karzon DT. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J Clin Invest 1991; 88:1026-33.
5. Openshaw PJ, Culley FJ, Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine 2001; 20 (Suppl. 1):S27-31.
6. Hall CB Respiratory Syncytial Virus. In: Textbook of Pediatric Infectious Diseases. Feigin RD, Cherry JD, eds. Philadelphia: W.B. Saunders Co., 1998:2084-111.
7. Wohl MEB. Bronchiolitis. In: Kendig's Disorders of the Respiratory Tract in Children. Chernick V, Kendig EL, eds. Philadelphia: W.B. Saunders Co., 1998:473-85.
8. O'Donnell DR, Carrington D. Peripheral blood lymphopenia and neutrophilia in children with severe respiratory syncytial virus disease. Pediatr Pulmonol 2002; 34:128-30.
9. de Weerd W, Twilhaar WN, Kimpen JLT. cell subset analysis in peripheral blood of children with RSV bronchiolitis. Scand J Infect Dis 1998; 30:77-80.
10. Coovadia HM, Wesley A, Brain P, Henderson LG, Hallett AF, Vos GH. Immunoparesis and outcome in measles. Lancet 1977; 1:619-21.
11. Wong RS, Wu A, To KF et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br Med J 2003; 326:1358-62.
12. Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171-86.
13. Budd RC. Activation-induced cell death. Curr Opin Immunol 2001; 13:356-62.
14. Zarozinski CC, McNally JM, Lohman BL, Daniels KA, Welsh RM. Bystander sensitization to activation-induced cell death as a mechanism of virus-induced immune suppression. J Virol 2000; 74:3650-8.
15. Reddy P, Teshima T, Kukuruga M, Ordemann R, Liu C, Lowler K, Ferrara JL. Interleukin-18 Regulates Acute Graft-Versus-Host Disease by Enhancing Fas-mediated Donor T Cell Apoptosis. J Exp Med 2001; 194:1433-40.
16. Roman M, Calhoun WJ, Hinton KL, Avendano LF, Simon V, Escobar AM, Gaggero A, Diaz PV. Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am J Respir Crit Care Med 1997; 156:190-5.
17. O'Donnell DR, Milligan L, Stark JM. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 1999; 257:198-207.
18. Rohwedder A, Keminer O, Forster J, Schneider K, Schneider E, Werchau H. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol 1998; 54:320-7.
19. O'Donnell DR, McGarvey MJ, Tully JM, Balfour-Lynn IM, Openshaw PJ. Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection. J Pediatr 1998; 133:272-4.
20. Okada H, Kobune F, Sato TA et al. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch Virol 2000; 145:905-20.
21. Baize S, Leroy EM, Georges-Courbot MC et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999; 5:423-6.
22. Barr J, Chambers P, Pringle CR, Easton AJ. Sequence of the major nucleocapsid protein gene of pneumonia virus of mice: sequence comparisons suggest structural homology between nucleocapsid proteins of pneumoviruses, paramyxoviruses, rhabdoviruses and filoviruses. J Gen Virol 1991; 72:677-85.
23. Hotchkiss RS, Tinsley KW, Swanson PE et al. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001; 166:6952-63.
24. Hotchkiss RS, Chang KC, Swanson PE et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000; 1:496-501.
25. Lee N, Hui D, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003; 348:1986-94.
26. Panesar NS. Lymphopenia in SARS. Lancet 2003; 361:1985.
27. O'Donnell R, Tasker RC, Roe MFE. SARS: understanding the coronavirus: Apoptosis may explain lymphopenia of SARS. Br Med J 2003; 327:620-62b.
28. Akdis M, Trautmann A, Klunker S et al. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 2003; 17:1026-35.
29. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161:1501-7.
30. O'Donnell DR, Openshaw PJM. Anaphylactic sensitization to aeroantigen during respiratory virus infection. Clin Exp Allergy 1998; 28:1501-8.
31. Peebles RSJ, Sheller JR, Johnson JE, Mitchell DB, Graham BS. Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice. J Med Virol 1999; 57:186-92.
32. Martinez FD. Viruses and atopic sensitization in the first years of life. Am. J Respir Crit Care Med 2000; 162:S95-S99.
33. Preston FM, Beier PL, Pope JH. Infectious respiratory syncytial virus (RSV) effectively inhibits the proliferative T cell response to inactivated RSV in vitro. J Infect Dis 1992; 165:819-25.
34. Chang J, Braciale TJ. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 2002; 8:54-60.
35. Alwan WH, Kozlowska WJ, Openshaw PJ. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 1994; 179:81-9.
36. Openshaw PJ. Immunity and immunopathology to respiratory syncytial virus. The mouse model. Am J Respir Crit Care Med 1995; 152:859-862.
37. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 1998; 10:259-64.
38. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168:633-9.
39. van Benten IJ, van Drunen CM, Koopman LP et al. RSV-induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response. J Med Virol 2003; 71:290-7.